In the construction of multi-level medical security system, city-customized medical insurance (hereinafter referred to as Huiminbao) is the middle layer connecting basic medical insurance and commercial insurance, which is a guarantee to resolve the risk of major diseases and promote common prosperity. This article clarifies the position of Huiminbao in the multi-level medical security system, analyzes the status of Huiminbao's participation rate, compensation rate and products, summarizes the problems such as insufficient insurance participation rate, poor structure of the insured population, unstable compensation rate and unequal compensation. This article proposes the model of paying according to the disease group based on DRG/DIP, which helps improve the insurance participation rate, optimize the structure of insurance participation and enhance the sense of acquisition of the insured on the basis of not affecting the interests of the relevant subjects. In addition, it also helps to attract healthy people to insure, effectively improve the inclusiveness and sustainability of the system, and make contribution to the construction of multi-level medical security system.
Key words
city-customized medical insurance /
inclusive insurance /
sustainable development /
payment according to the disease group
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 苏泽瑞.普惠性商业健康保险:现状、问题与发展建议[J].行政管理改革,2021(11):90-99.
[2] 刘云堃,杨强,董田甜.“惠民保”可持续发展的协同治理模式探究——基于江苏典型地区的比较分析[J].中国卫生政策研究,2022,15(04):30-35.
[3] 《“惠民保”发展模式研究》课题组,金小桃,王琴等.”惠民保”发展模式研究[J].保险研究,2022,405(01):3-20.
[4] 蔺淼,丁锦希.“惠民保”城市定制型商业医疗保险的制度创新与优化设计[J].价格理论与实践,2023(04):148-152.
[5] 于保荣,贾宇飞,孔维政,等.中国普惠式健康险的现状及未来发展建议[J].卫生经济研究,2021,38(04):3-8.
[6] 张宗良,褚福灵.中国多层次医疗保障体系再思考——兼析补充保障的模式创新与协同发展[J].经济社会体制比较,2023,225(01):79-92.
[7] 吴传俭.健康保险融合普惠金融和医疗救助的应急救助机制研究[J].保险理论与实践,2020(6):50-61.
[8] 孙巧慧.城市普惠医疗险发展问题探讨[J].金融理论与实践,2021,501(04):102-108.
[9] 徐雪萍,刘泽瑶,马东青,等.多中心治理:“惠民保”可持续发展的路径探索[J].卫生经济研究,2022,39(10):48-51.
[10] 宋占军,董李娜.城市普惠型医疗保险辨析及展望[J].上海保险,2021,423(01):16-18.
[11] 许荣庭,沈袁恒.普惠型医疗保险发展:实践困境与优化方向[J].西南金融,2022,486(01):40-51.
[12] 许燕.健康养老视角下商业健康保险需求的影响因素分析——以辽宁省数据为例[J].金融理论与实践,2016(02):110-113.
[13] 苏泽瑞.普惠性商业健康保险:现状、问题与发展建议[J].行政管理改革,2021,147(11):90-99.
[14] 郑功成.全面深化医保改革:进展、挑战与纵深推进[J].行政管理改革,2021,146(10):12-25.
[15] 李乐乐,李怡璇.我国医保支付方式改革的治理路径分析——基于DRG与DIP的机制比较[J].卫生经济研究,2022,39(09):43-48.
[16] 邵宁军,严欣.金华医保“病组点数法”付费改革成效评析[J].中国医疗保险,2018(4):41-43.
[17] 异地就医结算、集采、罕见病保障......政府工作报告中的医保清单[EB/OL].(2022-03-17)[2023-09-02].http://ybj.wuhan.gov.cn/bmdt/ztjy/202203/t20220317_1940950.shtml.
[18] 中国保险行业协会.2021中国保险业社会责任报告[R].2021.
[19] 许闲.2022年城市定制型商业医疗保险(惠民保)知识图谱[EB/OL].2022:4-9.
[20] 2022年惠民保全国“地图”出炉:263款产品覆盖29个省级行政区,三大制约如何破解?[EB/OL].(2022-12-16)[2023-09-02].https://rmh.pdnews.cn/Pc/ArtInfoApi/article?id=32936021.
[21] 浙江省医疗保障局.关于深化浙江省惠民型商业补充医疗保险改革的指导意见[EB/OL].(2022-11-22)[2023-09-02].http://ybj.zj.gov.cn/art/2022/11/22/art_1229113757_2447998.html.
[22] 张琳,杨卫平,等.“惠民保”产品研究蓝皮书(2022)[Z].2022:7-16.